Endoplasmic Reticulum α-Glucosidases I and II Inhibitor
EB-0156 is a potent inhibitor of endoplasmic reticulum α-glucosidases I and II, exhibiting IC50 values of 0.0479 μM and less than 0.001 μM, respectively. Derived from valiolamine, this compound demonstrates broad-spectrum antiviral activity. EB-0156 is valuable for research focused on developing therapeutic agents against both existing and emerging viral pathogens.
EB-0156 is a potent inhibitor of endoplasmic reticulum α-glucosidases I and II, exhibiting IC50 values of 0.0479 μM and less than 0.001 μM, respectively. Derived from valiolamine, this compound demonstrates broad-spectrum antiviral activity. EB-0156 is valuable for research focused on developing therapeutic agents against both existing and emerging viral pathogens.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
